Entera Bio Ltd.
ENTX
$2.17
-$0.12-5.24%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 82.00K | 42.00K | 57.00K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 82.00K | 42.00K | 57.00K | -- | -- |
| Cost of Revenue | 82.00K | 42.00K | 48.00K | -- | -- |
| Gross Profit | 0.00 | 0.00 | 9.00K | -- | -- |
| SG&A Expenses | 1.14M | 1.54M | 1.09M | 1.33M | 973.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -10.00K |
| Total Operating Expenses | 2.42M | 3.06M | 2.22M | 2.06M | 1.96M |
| Operating Income | -2.34M | -3.02M | -2.17M | -2.06M | -1.96M |
| Income Before Tax | -2.34M | -3.02M | -2.15M | -2.02M | -2.00M |
| Income Tax Expenses | 14.00K | -- | -- | -- | 0.00 |
| Earnings from Continuing Operations | -2.36M | -3.02M | -2.15M | -2.02M | -2.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.36M | -3.02M | -2.15M | -2.02M | -2.00M |
| EBIT | -2.34M | -3.02M | -2.17M | -2.06M | -1.96M |
| EBITDA | -2.33M | -3.01M | -2.15M | -2.05M | -1.95M |
| EPS Basic | -0.06 | -0.08 | -0.06 | -0.05 | -0.07 |
| Normalized Basic EPS | -0.04 | -0.05 | -0.04 | -0.03 | -0.04 |
| EPS Diluted | -0.06 | -0.08 | -0.06 | -0.05 | -0.07 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.04 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 39.11M | 37.64M | 37.09M | 36.74M | 29.59M |
| Average Diluted Shares Outstanding | 39.11M | 37.64M | 37.09M | 36.74M | 29.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |